cyclosporine has been researched along with Acute Symptom Flare in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Camprodon-Gómez, M; Fernández-Codina, A; Pope, JE | 1 |
| Axelrad, JE; Freedberg, DE; Varma, S; Verma, A | 1 |
| Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C | 1 |
| Busmanis, I; Lee, HY; Lian, BS | 1 |
| Aldredge, L; Armstrong, AW; Yamauchi, PS | 1 |
2 review(s) available for cyclosporine and Acute Symptom Flare
| Article | Year |
|---|---|
Interventions for cutaneous disease in systemic lupus erythematosus.
Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up | 2021 |
Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Insurance, Health, Reimbursement; Keratolytic Agents; Medication Adherence; Methotrexate; Psoriasis; Symptom Flare Up; Thalidomide | 2016 |
4 other study(ies) available for cyclosporine and Acute Symptom Flare
| Article | Year |
|---|---|
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
Giant Calcinosis in Dermatomyositis and Scleroderma Overlap.
Topics: Calcinosis; Cyclosporine; Dermatomyositis; Drainage; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Muscle Weakness; Raynaud Disease; Scleroderma, Systemic; Skin Diseases; Subcutaneous Tissue; Symptom Flare Up; Thoracic Wall; Tomography, X-Ray Computed | 2020 |
A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
Topics: Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Emergency Service, Hospital; Female; Hospitalization; Humans; Hypoalbuminemia; Hypotension; Immunosuppressive Agents; Infliximab; Length of Stay; Male; Middle Aged; Salvage Therapy; Severity of Illness Index; Symptom Flare Up; Tachycardia; Tumor Necrosis Factor Inhibitors | 2022 |
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
Topics: Alopecia; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Dermatologic Agents; Drug Hypersensitivity Syndrome; Humans; Male; Middle Aged; Prednisolone; Skin; Sulfasalazine; Symptom Flare Up; Treatment Outcome; Vitiligo | 2018 |